PULSATILE THYROTROPIN AND PROLACTIN SECRETION IN A MIXED THYROTROPIN-SECRETING AND PROLACTIN-SECRETING PITUITARY-ADENOMA

被引:6
作者
ADRIAANSE, R [1 ]
BRABANT, G [1 ]
ENDERT, E [1 ]
BEMELMAN, FJ [1 ]
WIERSINGA, WM [1 ]
机构
[1] HANNOVER MED SCH,HANNOVER,GERMANY
关键词
D O I
10.1530/eje.0.1300113
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The circadian and pulsatile thyrotropin (TSH) and prolactin (PRL) release was investigated in a patient with slight hyperthyroidism due to a mixed TSH- and PRL-secreting pituitary adenoma. Blood was withdrawn every 10 min for 24 h (before and after medical treatment); purse characteristics were analyzed by Desade and Cluster programs (values as mean+/-SD). The inappropriately high mean 24-h TSH concentration of 3.55+/-0.31 mU/l was associated with a higher mean 24-h TSH pulse amplitude but unaltered mean 24-h TSH pulse frequency relative to healthy controls. The nocturnal TSH surge (absolute surge 0.5 mU/l, relative surge 16%) was low, related to a loss of the usual nocturnal increase of TSH pulse amplitude and TSH purse frequency. Chronic treatment with octreotide resulted in a modest clinical and biochemical improvement of the hyperthyroid state; addition of bromocriptine at a later stage had no further beneficial effect. At the end of the follow-up period the mean 24-h TSH paradoxically had increased to 5.33+/-0.81 mU/l. The nocturnal TSH surge also increased (absolute surge 1.9 mU/l, relative surge 42%), but circadian changes in TSH pulsatility remained absent. In the untreated period the increased mean 24-h PRL concentration of 234+/-24 mu g/l was associated with an increased mean 24-h PRL amplitude, whereas the 24-h PRL pulse frequency (N=4) was lower relative to controls. No circadian PRL rhythm was present. After octreotide and bromocriptine treatment the mean 24-h PRL concentration and mean 24-h PRL pulse amplitude were unchanged, but a clear nocturnal increase of PRL now was observed. Analysis of the temporal coupling between TSH and PRL release by bivariate autoregressive modeling revealed significant cross-correlations in all three periods investigated (coefficients in the range 0.34-0.76, median 0.52; p<0.01) between TSH and PRL concentrations with a lag time of 10-20 min. We conclude that pulsatile TSH and PRL release in this mixed TSH- and PRL-secreting pituitary adenoma was autonomous in nature. The observed dampening of the nocturnal increase of TSH and PRL is putatively related to a lack of TRH receptors in these tumors. The observed co-secretion of TSH and PRL suggests synthesis of both hormones by the same cell.
引用
收藏
页码:113 / 120
页数:8
相关论文
共 48 条
[41]  
VELDHUIS JD, 1986, AM J PHYSIOL, V250, pE484
[42]   SECONDARY HYPER-THYROIDISM DUE TO THYROTROPIN HYPER-SECRETION - STUDY OF PITUITARY-TUMOR MORPHOLOGY AND THYROTROPIN CHEMISTRY AND RELEASE [J].
WALDHAUSL, W ;
BRATUSCHMARRAIN, P ;
NOWOTNY, P ;
BUCHLER, M ;
FORSSMANN, WG ;
LUJF, A ;
SCHUSTER, H .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1979, 49 (06) :879-887
[43]   THE EFFECT OF SOMATOSTATIN ANALOG ON CHIASMAL DYSFUNCTION FROM PITUITARY MACROADENOMAS [J].
WARNET, A ;
TIMSIT, J ;
CHANSON, P ;
GUILLAUSSEAU, PJ ;
ZAMFIRESCU, F ;
HARRIS, AG ;
DEROME, P ;
COPHIGNON, J ;
LUBETZKI, J .
JOURNAL OF NEUROSURGERY, 1989, 71 (05) :687-690
[44]   SHRINKAGE OF A PRIMARY THYROTROPIN-SECRETING PITUITARY-ADENOMA TREATED WITH THE LONG-ACTING SOMATOSTATIN ANALOG OCTREOTIDE (SMS-201-995) [J].
WARNET, A ;
LAJEUNIE, E ;
GELBERT, F ;
DUET, M ;
CHANSON, P ;
COPHIGNON, J ;
HARRIS, AG .
ACTA ENDOCRINOLOGICA, 1991, 124 (04) :487-491
[45]   INAPPROPRIATE SECRETION OF THYROID-STIMULATING HORMONE [J].
WEINTRAUB, BD ;
GERSHENGORN, MC ;
KOURIDES, IA ;
FEIN, H .
ANNALS OF INTERNAL MEDICINE, 1981, 95 (03) :339-351
[46]   LONG-TERM TREATMENT WITH THE SOMATOSTATIN ANALOG SMS-201-995 IN A PATIENT WITH A THYROTROPIN-SECRETING AND GROWTH HORMONE-SECRETING PITUITARY-ADENOMA [J].
WEMEAU, JL ;
DEWAILLY, D ;
LEROY, R ;
DHERBOMEZ, M ;
MAZZUCA, M ;
DECOULX, M ;
JAQUET, P .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 66 (03) :636-639
[47]  
WERNER S, 1979, HORM METAB RES, V11, P452, DOI 10.1055/s-0028-1095788
[48]  
WIERSINGA WM, 1982, METHOD ENZYMOL, V84, P272